Anxiety Disorders Mental and Behavioural Disorders Anxiety disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Families of anxious children aged under 10 years. Patients will be included in the trial if they score at or above the suggested clinical cut-off for an internalising disorder on the child behaviour checklist (the primary outcome measure). However, to ensure that all participants are of clinical severity, they must also have a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnosis of an anxiety disorder, assessed by the Anxiety Disorders Interview Schedule for Children (not including specific phobia, obsessive compulsive disorder, post-traumatic stress disorder/acute stress disorder, anxiety due to a general medical condition, or substance induced anxiety disorder). Participants will not be excluded on the grounds of other comorbid conditions.
Exclusion criteria
Exclusion criteria: Parents or children with moderate to severe learning disabilities will not be included in the study. Children whose parents do not have adequate English to benefit from the group format of the intervention will not be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome point is after 10 weeks participation in the trial, comparing those who have received the new intervention, and those who have remained on a waiting list. The primary outcome measure will be parent report of ?internalising symptoms? on the ?Child Behavior Checklist?. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome point is after 12 months in the trial where those who received the new intervention, and those who remained on a waiting list for at least 10 weeks before receiving ?treatment as usual? will be compared. The secondary outcome measures are teacher report of ?internalising symptoms? on the ?Child Behavior Checklist ? teacher report form?; and DSM-IV Anxiety Disorder diagnosis. | — |
Countries
United Kingdom